By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CytomX Therapeutics, Inc. 

650 Gateway Boulevard
Suite 125
South San Francisco  California  94080-7014  U.S.A.
Phone: 650-515-4987 Fax: 650-351-0353


SEARCH JOBS


Industry
Biotechnology






Company News
South San Francisco's CytomX Therapeutics, Inc. Inks Potential $348 Million Cancer-Fighting Deal With Bristol-Myers Squibb Company (BMY) 5/27/2014 6:25:35 AM
CytomX Therapeutics, Inc. To Present Data From Anti-Jagged Probody Program At Upcoming American Association for Cancer Research Annual Meeting 2014 3/26/2014 7:25:39 AM
CytomX Therapeutics, Inc. and ImmunoGen, Inc. (IMGN) Announce Strategic Collaboration to Develop Probody-Drug Conjugates Against Cancer Targets 1/9/2014 7:56:38 AM
CytomX Therapeutics, Inc. Presents Data for First-in-Class Jagged Probody™ Program at American Association for Cancer Research-American Association for Cancer Research-EORTC International Conference 10/23/2013 7:02:18 AM
CytomX Therapeutics, Inc. to Present at 12th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/1/2013 6:28:03 AM
CytomX Therapeutics, Inc.Announces Appointment of Krishna Polu, M.D., as Chief Medical Officer; Promotion of Debanjan Ray, MBA, to Vice President, Business Development 7/16/2013 10:21:05 AM
Pfizer Inc. (PFE), SF-Based CytomX Therapeutics, Inc. Ink $635 Million Oncology Deal 6/6/2013 7:41:02 AM
CytomX Therapeutics, Inc. Named a 2013 Red Herring Top 100 North America Tech Startup 6/3/2013 11:00:52 AM
CytomX Therapeutics, Inc. Expands Series B Financing; Canaan Partners Joins Syndicate 7/31/2012 10:00:20 AM
CytomX Therapeutics, Inc. Appoints Hoyoung Huh, M.D., Ph.D., Chairman of Board of Directors 3/6/2012 6:26:36 AM
12
//-->